Sage Therapeutics Inc. stock soared more than 70% Thursday to mark its biggest-ever one-day price and percentage gain, after the company reported positive results in a mid-stage trial of a treatment for severe depression that could offer doctors a new mechanism to treat the disease.
Latest posts by Market Watch (see all)
- The Moneyist: My ex-wife stopped payments on our home and racked up credit-card debt in my name - June 22, 2018
- These companies are expected to profit from Trump’s continued ‘zero-tolerance’ policy at the border - June 22, 2018
- Bond Report: Treasury yields end lower for the week as global trade tensions spur haven demand - June 22, 2018